18F-Sodium Fluoride PET/CT and PET/MR Imaging of Bone and Joint Disorders

PET Clin. 2018 Oct;13(4):477-490. doi: 10.1016/j.cpet.2018.05.004. Epub 2018 Aug 17.

Abstract

18F-sodium fluoride (18F-NaF) PET/CT provides high sensitivity and specificity for the assessment of bone and joint diseases. It is able to accurately differentiate malignant from benign bone lesions, especially when using dynamic quantitative approaches. Its high-quality, clinical accuracy, and high feasibility for patient management and greater availability of PET/CT scanners as well as decreasing trend of the cost of radiotracer all indicate the need to consider the use of 18F-NaF PET/CT as standard bone imaging, particularly in malignant diseases of the skeleton.

Keywords: (18)F-NaF; Benign bone disease; Malignant bone disease; PET/CT; PET/MR imaging.

Publication types

  • Review

MeSH terms

  • Bone Diseases / diagnosis*
  • Bone Diseases / economics
  • Costs and Cost Analysis
  • Diagnosis, Differential
  • Feasibility Studies
  • Fluorine Radioisotopes*
  • Fractures, Bone / diagnosis
  • Humans
  • Joint Diseases / diagnosis*
  • Joint Diseases / economics
  • Joint Prosthesis
  • Magnetic Resonance Imaging / economics
  • Magnetic Resonance Imaging / methods
  • Multimodal Imaging / methods
  • Positron Emission Tomography Computed Tomography / economics
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / economics
  • Positron-Emission Tomography / methods
  • Prosthesis Failure
  • Radiopharmaceuticals*
  • Sodium Fluoride*

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Sodium Fluoride